![]() |
市场调查报告书
商品编码
1308675
2030 年自动 ESR 分析仪市场预测 – 按类型、分析时间、模式、应用、最终用户和地区进行的全球分析Automated ESR Analyzer Market Forecasts to 2030 - Global Analysis By Type (Semi-Automated ESR Analyzer & Fully Automated ESR Analyzer), Analysis Time (Less Than 15 Min, 15-30 Min & More Than 30 Min), Modality, Application, End User & By Geography |
根据 Stratistics MRC 的数据,2023 年全球自动化 ESR 分析仪市场规模将达到 3.7572 亿美元,预测期内復合年增长率为 6.8%,预计到 2030 年将达到 5954.7 亿美元达到100万美元。
自动红细胞沉降率 (ESR) 分析仪计算红细胞从全血落入标准管中的速率(以毫米/小时为单位)。 自动化 ESR 分析仪可提供快速、准确的结果,同时减少劳动密集型手动工作以及与传统手动 ESR 测量相关的潜在错误。 实际上,它有助于防止多个样本被拒绝。 通过自动化技术获得快速、准确的 ESR 测量结果,并且与传统 Westergreen 参考方法表现出极好的一致性。 现代 ESR 方法不需要进一步稀释,提高了操作员的安全性,优化了实验室物流流程并减少了浪费。
根据世界卫生组织的数据,2018 年全球 ESR 报告约占医疗保健相关感染的 10% 和手术部位感染的 50%。
世界各国政府都在尖端医疗检测技术上投入更多资金。 日本、中国和印度等一些国家的感染率很高。 各国政府正在投入巨资为更多人提供健康和福祉。 为了减轻医疗保健服务的负担,特别是在新兴经济体,多个监管机构和政府推出了各种削减成本的措施。 所有这些因素都在推动市场需求。
处理血液样本的医护人员感染血液传播疾病的风险很大。 ESR 显着增加(>100mm/h)的最常见原因包括感染、大量出血、恶性肿瘤和颞关节炎。 这些会导致肾臟损伤和癌症损伤。 因此,不应鼓励当地测试中心和不熟练的操作人员来预防此类问题。 因此,传染病的威胁进一步阻碍了市场的扩张。
为了实现快速检测率,製造商正在开发最先进的设备,例如自动 ESR 分析仪。 现代分析仪直接从 EDTA 管提供 ESR 结果,无需使用患者样本。 这些分析仪具有最先进的编程、升级的测量算法和数据处理能力。 影响全球市场的技术进步使得自动 ESR 分析仪相对于手动 ESR 分析仪的市场开发得以实现。
ESR 分析仪是一种复杂的设备,需要合格的人员进行血液测试并获得正确的结果。 缺乏经验的技术人员可能会在订单输入、患者和样本识别、样本采集以及错误的测试请求等方面犯错误。 患者出现问题的风险仍然相当高。 在低收入国家,合格人才的短缺可能导致难以满足市场需求。
新冠疫情将对市场产生积极影响。 该病毒传播得如此之快,以至于世界各地的人们都必须接受血液检查。 血液检测分析被用作识别 COVID-19 阳性患者的替代方法。 患者的全血细胞计数(CBC)、血浆C反应蛋白(CRP)水平和红细胞沉降率均使用ESR分析仪测定。 借助自动化 ESR 分析仪,实验室能够在短时间内获得准确的结果。 每天进行数千次血液检查。 这种时尚给市场带来了巨大的好处。
全自动 ESR 分析仪领域预计将有良好的增长。 全自动分析仪可提高生产率、交货时间和实验室安全性。 从插入样品管的那一刻起,即可进行无人值守操作。 因此,它比半自动ESR分析仪更实用。 通过最先进的全自动模型,对儿科患者的分析变得更加容易。 该行业的增长是由这些因素推动的。
在预测期内,便携式市场预计将以最快的复合年增长率增长。 便携式ESR分析仪是一种采用Westergren分析方法和红外传感器测量方法的便携式设备。 最大处理速度为每小时 80 个样品,测量范围为 1 至 140 mm/h。 大多数仪器有两次测量时间,每次测量时间为 30 或 60 分钟,最多可同时加载 40 个样品。 用户友好且易于识别患者的优点推动了这一细分市场的需求。
由于传染病、炎症、心脏病、血液疾病、糖尿病和胶原血管疾病等疾病的患病率不断上升,预计欧洲在预测期内将占据最大的市场份额。我在这里。 欧洲是获取准确和最新的全球癌症统计数据的关键地区,因为它对全球癌症负担做出了重大贡献。 由于自动化 ESR 分析仪与当前的恶性肿瘤状况相关,因此随着癌症发病率的上升,德国对自动化 ESR 分析仪的需求很可能仍将保持在较高水平。
由于血源性感染增加,预计亚太地区在预测期内的复合年增长率最高。 该地区卫生设施不足是感染在人群中传播的一个关键标准。 随着全自动检测系统在亚太地区的推出,日本目前在全球享有较大的市场份额。 这是由于老年人口众多以及与年龄相关的疾病负担沉重。 此外,由于政府注重加强医疗基础设施并为其公民提供改善的医疗设施,该地区的工业正在增长。
2023 年 5 月,临床诊断领导者 Beckman Coulter 宣布推出单位面积生产率最高的 DxI 9000 Access 免疫分析仪。 DxI 9000 分析仪每小时每平方米最多可执行 215 次测试(测试/小时/平方米)。 DxI 9000 分析仪的创新满足了速度、可靠性、再现性、质量和菜单扩展的要求。
2022 年 3 月,Thermo Fisher Scientific 发布了最新一代 SeqStudio Flex 系列基因分析仪,支持客户在基因编辑和传染病等领域进行前沿研究。 SeqStudio Flex 基因分析仪提供最高标准的 CE 技术质量、准确的数据和可靠的性能。
According to Stratistics MRC, the Global Automated ESR Analyzer Market is accounted for $375.72 million in 2023 and is expected to reach $595.47 million by 2030 growing at a CAGR of 6.8% during the forecast period. The automated erythrocyte sedimentation rate (ESR) analyzer calculates the rate in mm per hour at which red blood cells from whole blood fall into a standard tube. Automated ESR analyzers deliver prompt and precise findings while cutting down on the labor-intensive manual work and potential mistakes that come with conventional manual methods of ESR measurement. In practical practice, it aids in preventing the rejection of several samples. Rapid and accurate ESR readings are produced using an automated technique, which also exhibits excellent agreement with the conventional Westergreen reference method. Modern ESR methods do not require further dilution, which enhances operator security, optimizes logistical laboratory process, and reduces waste.
According to the World Health Organization, by worldwide ESR reports in 2018, healthcare associated infection was about 10% and surgical site infections were 50%.
Governments all across the world are spending additional funds on cutting-edge medical testing technology. Infection rates are high in several countries, including Japan, China, and India. Governments are making large expenditures to provide greater health and well-being for more people. To lessen the burden of providing healthcare, several regulatory bodies and governments, particularly in developed economies, are putting in place a variety of cost-cutting measures. All of these factors boost the market demand.
Medical personnel who handle blood samples run a very real risk of contracting a blood-borne illness. The most prevalent causes of a highly increased ESR (>100 mm/hr) include infection, significant blood loss, malignancy, or temporal arthritis. They may result in renal or cancer disorders. Therefore, in order to prevent such issues, local testing centers and unskilled operators should not be encouraged. Therefore, the threat of infections is impeding market expansion even more.
In order to offer a quick detection rate, manufacturers are creating cutting-edge equipment like automated ESR analyzers. The newest developments in analyzers give ESR findings straight from EDTA tubes without using the patient sample. These analyzers have cutting-edge programming, upgraded measuring algorithms, and increased data-handling capabilities. The development of automated ESR analyzers beyond manual ESR analyzers is currently possible because to technological advancements, which are influencing the worldwide market.
ESR analyzers are intricate devices that need for qualified personnel to do blood tests and provide correct findings. Unskilled technicians may make mistakes in order input, patient and specimen identification, sample collection, and incorrect test requests. Patients still run a considerable risk of developing problems. Low-income nations may experience difficulties meeting market demand due to a lack of qualified personnel.
The covid pandemic has the positive impact on the market. As the virus spread rapidly, it became necessary for all the people around the world to have blood tests. Blood test analysis is used as an alternative for identifying COVID-19-positive patients. The patient's complete blood count (CBC), plasma levels of C-reactive protein (CRP), and erythrocyte sedimentation rate were all examined using ESR analyzers. The laboratories received accurate outcomes in a shorter amount of time because of the automated ESR analyzers. Every day, thousands of blood tests were carried out. The epidemic profited the market hugely.
The fully automated ESR analyzer segment is estimated to have a lucrative growth. Fully automated analyzers enhance productivity, turnaround time, and lab security. From the moment the sample tube is inserted, it allows walk-away operation. This makes it more practical than ESR analyzers that are semi-automated. The analysis of paediatric patients is made simpler when cutting-edge, completely automated analyser models are employed. The segment's growth is being fuelled by these factors.
The portable segment is anticipated to witness the fastest CAGR growth during the forecast period. Portable ESR analyzers are portable devices that employ the Westergren analysis technique and the infrared sensor measuring idea. They have an hourly processing rate of up to 80 samples and a measurement range of 1 to 140 mm/h. The majority of devices have two measurement times of 30 or 60 minutes each and a maximum simultaneous sample loading capacity of 40. The segment's demand is being fueled by its benefits for user-friendly and simple patient identification.
Europe is projected to hold the largest market share during the forecast period owing to the rising prevalence of disorders such infection, inflammation, heart disease, blood disease, diabetes, and collagen vascular diseases. Europe is a key area of attention for getting accurate and current global cancer statistics due to its large contribution to the global cancer burden. It is very likely that demand for automated ESR analyzers will stay high in Germany as cancer prevalence grows since ESR analyzers are linked to the symptoms of present malignancies.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to raising blood borne infections. Inadequate sanitation conditions in this region are the main criteria for growing infections among population. With the introduction of fully automated laboratory systems in the Asia Pacific area, Japan now enjoys a greater market share globally. This is attributed to the large geriatric population bringing in a heavy disease burden associated with age-related disorders. Additionally, the region's industry is growing as a result of the government's focus on enhancing the healthcare infrastructure and offering the populace improved healthcare facilities.
Some of the key players profiled in the Automated ESR Analyzer Market include ALCOR Scientific Inc, RR Mechatronics, Beijing Succeeder Technology Inc, Streck Inc, ELITechGroup, Greiner Bio One International GmbH, SFRI Medical Diagnostics, Alifax Holding S.p.A., Thermo Fisher Scientific Inc, Diesse Diagnostica Senese SPA, Hospitex Diagnostics, Caretium Medical Instruments Co, Streck Laboratories, Beckman Coulter Inc and Perlong Medical Equipment Co Ltd.
In May 2023, Beckman Coulter, a clinical diagnostics leader, unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2). The DxI 9000 Analyzer innovations address speed, reliability, reproducibility, quality, and menu expansion demands.
In March 2022, Thermo Fisher Scientific introduced its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease. The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.